Flu.seqirus.com is a subdomain of seqirus.com, which was created on 2015-05-08,making it 9 years ago.
Description:flu360 offers clinical, financial, and operational solutions for your flu vaccination business year-round. Learn more and partner with CSL Seqirus at...
Discover flu.seqirus.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 74.232 KB |
Page Load Time: 0.99894 Seconds |
Website IP Address: 51.145.135.103 |
CSL Global Newsroom newsroom.csl.com |
CSL in Session | Libraries Learn cslinsession.cvlsites.org |
NMDOH | Get the Facts about the COVID-19 Vaccine. getthefacts.vaccinenm.org |
NMDOH | Get the Facts about the COVID-19 Vaccine. cvvaccine.nmhealth.org |
COVID19 Vaccine Tracker covid19.trackvaccines.org |
CSL Behring Medical Affairs medicalaffairs.cslbehring.com |
Do the Amazing. Help save lives. Donate plasma. | CSL Plasma mobile.cslplasma.com |
DHHS: DPH: North Carolina Influenza Update flu.nc.gov |
CSL Docs | CSL Docs csl.cs.wisc.edu |
Target Seasonal Influenza Vaccination Rates and Barriers flu.baylorcme.org |
Sign In - Alliance Catering at CSL cslcatering.foodstorm.com |
FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) for 65+ | CSL Seqirus flu360 hcp.fluad.com |
Sony CSL – Paris csl.sony.fr |
Rapivab: Flu Antiviral https://flu.seqirus.com/rapivab/ |
Date: Tue, 14 May 2024 03:42:01 GMT |
Server: * |
X-Frame-Options: ALLOWALL |
Cache-Control: no-cache, no-store, max-age=0, must-revalidate |
Pragma: no-cache |
Expires: 0 |
Strict-Transport-Security: max-age=31536000 ; includeSubDomains |
X-XSS-Protection: 1; mode=block |
X-Content-Type-Options: nosniff |
Content-Type: text/html;charset=UTF-8 |
Content-Language: en |
Vary: Accept-Encoding,User-Agent |
Set-Cookie: JSESSIONID=3D278215AD75CE608788716A6789CC7E.accstorefront-748fd4689c-8wcvb; Path=/; Secure; HttpOnly; SameSite=None, anonymous-consents=%5B%7B%22templateCode%22%3A%22privacy.Seqirus_US_Privacy_Policy%22%2C%22templateVersion%22%3A1%2C%22consentState%22%3Anull%7D%2C%7B%22templateCode%22%3A%22terms.Seqirus_US_Terms_of_use%22%2C%22templateVersion%22%3A1%2C%22consentState%22%3Anull%7D%5D; Max-Age=31536000; Expires=Wed, 14 May 2025 03:42:01 GMT; Path=/; Secure; HttpOnly; SameSite=None, cookie-notification=NOT_ACCEPTED; Max-Age=360000000; Expires=Wed, 10 Oct 2035 19:42:01 GMT; Path=/; Secure; SameSite=None, ROUTE=.accstorefront-748fd4689c-8wcvb; Path=/; Secure; HttpOnly; SameSite=None |
Transfer-Encoding: chunked |
content="text/html; charset=utf-8" http-equiv="Content-Type"/ |
content="IE=edge" http-equiv="X-UA-Compatible"/ |
charset="utf-8"/ |
content="width=device-width, initial-scale=1, user-scalable=no" name="viewport"/ |
name="keywords"/ |
content="flu360 offers clinical, financial, and operational solutions for your flu vaccination business year-round. Learn more and partner with CSL Seqirus at flu360.com." name="description"/ |
content="UDj2gTX59qp677zGRRC4ChF5SaDlNEtXFWCFH2opcXk" name="google-site-verification"/ |
content="index,follow" name="robots"/ |
Ip Country: The Netherlands |
City Name: Amsterdam |
Latitude: 52.3759 |
Longitude: 4.8975 |
flu360® Influenza Vaccine Business & Healthcare Solutions | CSL Seqirus flu360 Please maximize your window to view this content. For US Healthcare Professionals Only For GB Healthcare Professionals Only Prescribing Information FLUAD ® QUADRIVALENT FLUCELVAX ® QUADRIVALENT AFLURIA ® QUADRIVALENT Important Safety Information FLUAD ® QUADRIVALENT FLUCELVAX ® QUADRIVALENT AFLURIA ® QUADRIVALENT About Support Log In For US Healthcare Professionals Only For GB Healthcare Professionals Only flu360 ® Overview Overview Clinical Support Adjuvant Technology Cell Technology Influenza Burden 65+ Years Influenza Burden Financial Guidance Coding and Billing Operational Efficiency Products All Products FLUAD ® QUADRIVALENT FLUCELVAX ® QUADRIVALENT AFLURIA ® QUADRIVALENT Tools & Resources Create Account flu360 ® Overview Overview Clinical Support Adjuvant Technology Cell Technology Influenza Burden 65+ Years Influenza Burden Financial Guidance Coding and Billing Operational Efficiency Products All Products FLUAD ® QUADRIVALENT FLUCELVAX ® QUADRIVALENT AFLURIA ® QUADRIVALENT Tools & Resources Important Safety Information FLUAD ® QUADRIVALENT FLUCELVAX ® QUADRIVALENT AFLURIA ® QUADRIVALENT Prescribing Information FLUAD ® QUADRIVALENT FLUCELVAX ® QUADRIVALENT AFLURIA ® QUADRIVALENT About Support Create Account Log In × Your session is about to time out. Any in-progress updates won’t be saved. Session timeout in: : Continue Session Log Out You are now being redirected to flu360 If the page does not redirect please click hereNeed help? View the guide here CSL Seqirus. Focused on Flu. Focused on you. We have available influenza vaccine supply to support your 2024-2025 vaccination campaign needs. Ready to get started? Create Account Need help? View the guide here Everything you need to simplify your vaccination business flu360® partners you with true flu professionals and solutions. Create an account to get started. flu360 Overview Brought to you by CSL Seqirus flu360 Solutions Built to help your clinic or network overcome challenges both unique and common. Clinical Support Discover influenza vaccine technologies, access vaccine expertise, and download clinic tools and resources. Financial Guidance Understand financial status, and manage invoices and payment methods. Operational Efficiency Place and track orders while managing inventory and overall performance. Explore flu360 Solutions We’re here to strengthen and support your flu vaccination efforts CSL Seqirus understands the complexities of managing flu vaccinations. When you sign up with flu360, you gain a dedicated partner, expert vaccination support and service, and access to CSL Seqirus’ differentiated flu vaccine portfolio. Create Account flu360 Overview Explore the CSL Seqirus Vaccine Portfolio Explore Explore Explore Please see Important Safety Information and full US Prescribing Information on each vaccine’s respective product page. Access Featured Resources FLUAD QUADRIVALENT | CLINICAL FLUAD ® QUADRIVALENT ACIP Recommendation Flyer Review a summary of the ACIP decision to preferentially recommend FLUAD QUADRIVALENT as seasonal influenza vaccine for adults 65+. Access Resource CLINICAL Flu Clinic Resource Toolkit Raise flu vaccination awareness among your patients with downloadable materials. Access Resource FINANCIAL CSL Seqirus Portfolio Coding and Billing Guide Access the latest coding and billing info for CSL Seqirus flu vaccines all in one place. Access Resource FLUAD QUADRIVALENT | CLINICAL FLUAD ® QUADRIVALENT ACIP Recommendation Flyer Review a summary of the ACIP decision to preferentially recommend FLUAD QUADRIVALENT as seasonal influenza vaccine for adults 65+. Access Resource CLINICAL Flu Clinic Resource Toolkit Raise flu vaccination awareness among your patients with downloadable materials. Access Resource FINANCIAL CSL Seqirus Portfolio Coding and Billing Guide Access the latest coding and billing info for CSL Seqirus flu vaccines all in one place. Access Resource View All Resources Brought to you by CSL Seqirus As a leading flu vaccine manufacturer and your partner in public health, CSL Seqirus is committed to working with you to grow your immunization clinic business through flu360. Create Account Learn About CSL Seqirus Select an account to view × You’re signed in as Visit Our Corporate Site at seqirus.us Navigate Home flu360 Overview Products Tools & Resources About Help & FAQs Cookie Policy Returns Website Terms of Use Terms and Conditions of Privacy Terms and Conditions of Returnability Terms and Conditions of Use Terms and Conditions of Sale - 2023-2024 Terms and Conditions of Sale - 2023-2024 as of April 2023 Terms and Conditions of Sale - 2024-2025 Terms and Conditions of Sale - 2024-2025 as of April 2024 Visit Our Corporate Site at seqirus.us AFLURIA ® QUADRIVALENT, flu360 ® , FLUAD ® QUADRIVALENT, FLUCELVAX ® QUADRIVALENT, MF59 ® , and WE’VE GOT FLU COVERED ® are trademarks of Seqirus UK Limited and its affiliates. Manufactured by: Seqirus Inc., 475 Green Oaks Parkway, Holly Springs, NC 27540, USA Distributed by: Seqirus USA Inc., 25 Deforest Avenue, Summit, NJ, 07901, USA ©2022 Seqirus USA Inc. November 2022 USA-FLU360-22-0147, USA-FLU360-22-0148, USA-FLU360-22-0149, USA-FLU360-22-0150(V2.0), USA-FLU360-22-0151, USA-FLU360-22-0152(V3.0), USA-FLU360-22-0153, USA-FLU360-22-0154, USA-FLU360-22-0155, USA-FLU360-22-0156, USA-FLU360-22-0157Cookie...
Domain Name: SEQIRUS.COM Registry Domain ID: 1926813989_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2024-04-06T09:04:39Z Creation Date: 2015-05-08T13:03:58Z Registry Expiry Date: 2026-05-08T13:03:58Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:05:52Z <<<